Spectrum Biochem Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 03-12-2024
- Paid Up Capital ₹ 3.00 M
as on 03-12-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.70 M
as on 03-12-2024
- Revenue 23.96%
(FY 2016)
- Profit 8.59%
(FY 2016)
- Ebitda 9.22%
(FY 2016)
- Net Worth -192.63%
(FY 2016)
- Total Assets -11.61%
(FY 2016)
About Spectrum Biochem
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.00 M.
The company has closed loans amounting to ₹2.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rahul Pawar and Unmesh Pawar serve as directors at the Company.
- CIN/LLPIN
U24232PN2013PTC146968
- Company No.
146968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2013
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Spectrum Biochem Private Limited offer?
Spectrum Biochem Private Limited offers a wide range of products and services, including Chromatography Column, HPLC Column, Laser Cutting Services, Metal Laser Cutting Service.
Who are the key members and board of directors at Spectrum Biochem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Unmesh Pawar  | Director | 17-Apr-2013 | Current |
| Rahul Pawar | Director | 17-Apr-2013 | Current |
Financial Performance of Spectrum Biochem.
Spectrum Biochem Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 23.96% increase. The company also saw a slight improvement in profitability, with a 8.59% increase in profit. The company's net worth observed a substantial decline by a decrease of 192.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spectrum Biochem?
In 2017, Spectrum Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Malwin Infratech Private LimitedActive 4 years 2 monthsRahul Pawar and Unmesh Pawar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Shamrao Vithal Co-Operative Bank Limited Creation Date: 02 Jan 2014 | ₹2.70 M | Satisfied |
How Many Employees Work at Spectrum Biochem?
Unlock and access historical data on people associated with Spectrum Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spectrum Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
